Tiny fish evolve rapidly and predictably by diving into a 'genetic toolbox' shared with other organisms including Darwin's finches.
With "bubbles" and "spacesuits," Stanford Medicine scientists take on the challenge of researching SARS-CoV-2 in the lab.
Stanford researchers and others created a project to increase the number of doctors who can provide diabetes care to underserved communities.
Stanford researchers investigate vaccine hesitancy and show how to better communication about vaccines to encourage acceptance.
Stanford Medicine researchers and others discovered 13 genetic signatures that are closely linked to an increased risk for severe COVID-19.
A new way to deliver mRNA as a COVID-19 vaccine may avoid side effects and increase customization to prevent infection.
Learning techniques to build resilience lowers the stress and anxiety of raising a child with autism, Stanford research found.
During the COVID-19 pandemic, workers innovated to quickly convert hospital rooms to isolation rooms at Stanford Health Care - ValleyCare.
The more that people do "contemplative practices," such meditation, the longer they abide by shelter-in-place guidelines, new study shows.
Anthony Oro is devoted to understanding the origin of basal cell carcinomas. Now he's found how some become resistant to a common treatment.
A team of researchers developed a model to simulate potential COVID-19 transmission in elementary and high schools, as well as households.
Through his words, Italo Brown’s accomplishments and his actions as an advocate for equity in health care, he has embraced the challenge of rising to the name and its expectations.
Stanford medical student from Sierra Leone calls for urgent improvements in efforts to protect the people of African nations against COVID-19.
New research shows that 65% of people in the US will be partially vaccinated by July 4 — but for Hispanic and Black people, rates are lower.
With COVID-19 information evolving daily, the Stanford Health Care pharmacy team had to prepare for the unexpected in its vaccine rollout.
Stanford researchers find that screening all adults in the United States one time for hepatitis B could save money and lives.